NCT00990782

Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment

CEPELA I Trial: Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 93 (actual)
• Sponsor: The Cleveland Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of a patient's esophagus before and after the RFA procedure, as the injury rate to the esophagus has not been established.

Detailed description

Patients undergoing radiofrequency ablation (RFA) therapy for atrial fibrillation, can sometimes experience insult or injury to the esophagus, due to the proximity of the esophagus to the RFA treatment area. This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of a patient's esophagus before and after the RFA procedure, as the injury rate to the esophagus has not been established.

Conditions

• Esophageal Lesion

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	PillCam ESO Capsule Endoscope	Utilization of the PillCam ESO capsule endoscope to evaluate the condition of a patient's esophagus before and after RFA therapy to treat atrial fibrillation.

Timeline

• Start date: 2009-09-01
• Primary completion: 2010-06-01
• Completion: 2010-09-01
• First posted: 2009-10-07
• Last updated: 2017-07-02
• Results posted: 2017-07-02

Locations

1 site across 1 country: United States